Carine Brinster
Overview
Explore the profile of Carine Brinster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasan Bou Issa L, Flechon L, Laine W, Ouelkdite A, Gaggero S, Cozzani A, et al.
iScience
. 2024 Mar;
27(4):109417.
PMID: 38510131
Multiple myeloma (MM) is an incurable hematological malignancy in which MYC alterations contribute to the malignant phenotype. Nevertheless, MYC lacks therapeutic druggability. Here, we leveraged large-scale loss-of-function screens and conducted...
2.
Ben Khoud M, Jouy N, Driss V, Quesnel B, Brinster C
J Interferon Cytokine Res
. 2023 Mar;
43(4):164-172.
PMID: 36927129
Acute myeloid leukemia (AML) is characterized by an increased proliferation and loss of differentiation of hematopoietic myeloid progenitors or precursors. Studies performed in AML-affected patients revealed a T cell deficiency...
3.
Mopin A, Lepretre F, Sebda S, Villenet C, Ben Khoud M, Figeac M, et al.
PLoS One
. 2022 Apr;
17(4):e0267508.
PMID: 35486629
Acute myeloid leukemia (AML) is characterized by blocked differentiation and extensive proliferation of hematopoietic progenitors/precursors. Relapse is often observed after chemotherapy due to the presence of residual leukemic cells, which...
4.
Shaik F, Lewuillon C, Guillemette A, Ahmadian B, Brinster C, Quesnel B, et al.
Lab Chip
. 2022 Jan;
22(5):908-920.
PMID: 35098952
Analyzing cell-cell interaction is essential to investigate how immune cells function. Elegant designs have been demonstrated to study lymphocytes and their interaction partners. However, these devices have been targeting cells...
5.
Ben Khoud M, Ingegnere T, Quesnel B, Mitra S, Brinster C
Cancers (Basel)
. 2021 Jun;
13(10).
PMID: 34069204
Acute myeloid leukemia (AML) is a heterogeneous disease driven by impaired differentiation of hematopoietic primitive cells toward myeloid lineages (monocytes, granulocytes, red blood cells, platelets), leading to expansion and accumulation...
6.
Driss V, Lepretre F, Briche I, Mopin A, Villenet C, Figeac M, et al.
Immunol Lett
. 2017 Oct;
192:27-34.
PMID: 29030252
Background: In acute myeloid leukaemia (AML)-affected patients, the presence of heterogeneous sub-clones at diagnosis has been shown to be responsible for minimal residual disease and relapses. The role played by...
7.
Mopin A, Driss V, Brinster C
J Vis Exp
. 2016 Oct;
(116).
PMID: 27768040
The intravenous injection of C1498 cells into syngeneic or congenic mice has been performed since 1941. These injections result in the development of acute leukemia. However, the nature of this...
8.
Driss V, Quesnel B, Brinster C
Eur J Immunol
. 2014 Nov;
45(2):396-406.
PMID: 25382729
Recent studies on acute myelogenous leukemia (AML) patients have revealed the existence of T-cell immunodeficiencies, characterized by peripheral T lymphocytes that are unable to interact with blasts, reduced thymic emigrants...
9.
Inaba K, Swiggard W, Steinman R, Romani N, Schuler G, Brinster C
Curr Protoc Immunol
. 2009 Aug;
Chapter 3:3.7.1-3.7.19.
PMID: 19653207
This unit presents two methods for preparing dendritic cells (DCs), a highly specialized type of antigen-presenting cell (APC). The first method involves the isolation of DCs from mouse spleen, resulting...
10.
Noel G, Brinster C, Semana G, Bruniquel D
Int Immunol
. 2009 Jul;
21(9):1025-36.
PMID: 19625380
In this study, we explored the potential of human naive CD4(+) T cells to acquire regulatory properties upon stimulation. We demonstrated that, in vitro, pre-activated naive CD4(+)CD25(-)CD45RA(+) T cells could...